Biochemistry and Biophysics
Anil Padyana joined Atavistik Bio in September 2021. As Vice President, Biochemistry and Biophysics, Anil leads discovery teams across early and late-stage research programs. He is an accomplished drug discovery leader with over 20 years of experience in the biotechnology and pharmaceutical industries. He brings deep expertise in molecular targets, lead discovery, mechanistic biochemistry, biophysics, and structure-based drug discovery (SBDD). Prior to joining Atavistik Bio, he held leadership roles at Agios Pharmaceuticals and Boehringer Ingelheim, contributing to drug discovery efforts across multiple therapeutic areas. He began his industry career at SGX Pharmaceuticals.
Anil has played a key role in the discovery and development of FDA-approved precision medicines, including IDHIFA®, SPEVIGO®, and VORANIGO®, as well as more than 12 investigational drugs that have advanced to clinical development. He is an author and co-inventor on over 50 scientific publications and patents.
Anil earned his PhD in Biophysics and Bioinformatics from the Indian Institute of Science (IISc), India. He was a postdoctoral fellow in the laboratory of Prof. Stephen Burley at Rockefeller University in New York.